Ledger.Open graph →
SEC Form D · filed July 13, 2020

Nerio Therapeutics, Inc

Offering
$5.8M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Stefan J. Heller · La Jolla, CADirectorTighe J. Reardon · La Jolla, CAExec · DirectorJay J. Lichter, Ph.D · La Jolla, CADirectorSteve Kurz · New York, NYDirectorChristopher Ferraro · New York, NYDirectorThomas C. Lynch, Jr · WASHINGTON, Washington, D.C.Exec · DirectorSanford J. Madigan, Ph.D · La Jolla, CAExec · DirectorMeltem Amiot-Karakoc · Luxembourg, LuxembourgDirectorKristian Schnittger · Luxembourg, LuxembourgDirectorRichard H. Coats · Midland, TXExec · DirectorSanford J. Madigan, Ph.D · La Jolla, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗